Insilico Medicine receives IND clearance from FDA for ISM5939, an oral ENPP1 inhibitor treating solid tumors EurekAlert! Peptide Therapy Prescription in 2025: Your Safe Guide The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Tesamorelin Peptide: FDA Approved Benefits, Results Timeline, and Who It's For Perfect B Doctor Explains The FDA Approved Peptide for BURNING Belly Fat (Tesamorelin Peptide) FDA Removes 14 Peptides from Category 2 to Category 1 Mansi Hukmani posted on the topic LinkedIn